Immunotherapy strategy for systemic autoimmune diseases: betting on CAR-T cells and antibodies

V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova… - Antibodies, 2024 - mdpi.com
Systemic autoimmune diseases (SAIDs), such as systemic lupus erythematosus (SLE),
systemic sclerosis (SSc) and rheumatoid arthritis (RA), are fully related to the unregulated …

Development of beta-amyloid-specific CAR-tregs for the treatment of alzheimer's disease

V Saetzler, T Riet, A Schienke, P Henschel, K Freitag… - Cells, 2023 - mdpi.com
Background: Alzheimer's disease (AD) is a neurodegenerative disease that remains
uncured. Its pathogenesis is characterized by the formation of β-amyloid (Aβ) plaques. The …

Sequential immunotherapy: towards cures for autoimmunity

F Ramírez-Valle, JC Maranville, S Roy… - Nature Reviews Drug …, 2024 - nature.com
Despite major progress in the treatment of autoimmune diseases in the past two decades,
most therapies do not cure disease and can be associated with increased risk of infection …

Expanding the role of CAR T‐cell therapy: From B‐cell hematological malignancies to autoimmune rheumatic diseases

R Shumnalieva, T Velikova… - International Journal of …, 2024 - Wiley Online Library
Chimeric antigen receptor (CAR) T‐cell therapy is a form of immunotherapy where the
lymphocytes, mostly T‐cells, are redirected to specifically recognize and eliminate a target …

[HTML][HTML] Application and research progress of CAR-T cell therapy in autoimmune diseases

X Yu, H Shang, X Shen, J Zhang, T Chang… - Gene & Protein in …, 2024 - accscience.com
The conventional clinical therapies for autoimmune diseases (ADs) lack specificity,
necessitating long-term medication that can lead to serious side effects. In contrast, chimeric …

[HTML][HTML] Towards personal gene and cell therapy: accelerating factors and roadblocks on point-of-care production approach

MY Samsonov, AM Lomonosov - Cell Ther Transplant, 2024 - cttjournal.com
Recent advances in gene and cell therapy showed impressive results over last decade that
culminated into approval of CAR-T therapies, ie, long-term remissions in hopeless cancer …

[PDF][PDF] Biotechnology in rheumatology and immunology for researchers: An overview

K Uthansingh, RN Padhy - researchgate.net
Biotechnology has revolutionized the fields of rheumatology and immunology, providing
innovative solutions for understanding and treating autoimmune diseases. Traditionally …

Shifting gears with CAR T cells for autoimmune diseases

B Kale, M Khosravi-Maharlooei, F Perna - Molecular Therapy, 2024 - cell.com
Just a few weeks ago at the American Society of Hematology Annual Meeting, Mueller et al.
presented remarkable data from their ongoing study testing CD19-directed chimeric antigen …